About SPORTIVO Network
0 Commentaires
0 Parts
801 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Clinical Oncology Next Generation Sequencing Market In-Depth Research Report with Industry Forecast"Global Executive Summary Clinical Oncology Next Generation Sequencing Market Market: Size, Share, and Forecast Data Bridge Market Research analyses that the clinical oncology next generation sequencing market which was USD 592.56 million in 2021, would rocket up to USD 1825.30 million by 2029, and is expected to undergo a CAGR of 15.1% during the forecast period 2022 to 2029. The complete...0 Commentaires 0 Parts 1KB Vue 0 Aperçu
-
Immuno Oncology Assays Market Overview: Key Drivers and ChallengesImmuno Oncology Assays Market Summary: According to the latest report published by Data Bridge Market Research, the Immuno Oncology Assays Market CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period DBMR...0 Commentaires 0 Parts 379 Vue 0 Aperçu
-
Immuno Oncology Assays Market: Insights and Competitive AnalysisExecutive Summary Immuno Oncology Assays Market Size and Share Across Top Segments CAGR Value The global immuno oncology assays market size was valued at USD 6.80 billion in 2025 and is expected to reach USD 16.45 billion by 2033, at a CAGR of 11.68% during the forecast period To better structure this Immuno Oncology Assays report, a nice blend of...0 Commentaires 0 Parts 601 Vue 0 Aperçu
-
Long-Acting Injectable Oncology Drug Market Size Forecast and Segment AnalysisAccording to the latest report published by Data Bridge Market Research, the Long-Acting Injectable Oncology Drug Market The global long-acting injectable oncology drug market size was valued at USD 7.16 billion in 2025 and is expected to reach USD 17.60 billion by 2033, at a CAGR of 11.90% during the forecast period Quality and transparency has been strictly maintained while...0 Commentaires 0 Parts 105 Vue 0 Aperçu
-
Taxane-Based Oncology Drug Class Market Overview: Key Drivers and Challenges 2025 –2032Executive Summary Taxane-Based Oncology Drug Class Market Market: Growth Trends and Share Breakdown CAGR Value The global taxane-based oncology drug class market size was valued at USD 7.21 billion in 2025 and is expected to reach USD 10.25 billion by 2033, at a CAGR of 4.50% during the forecast period This global Taxane-Based Oncology Drug Class Market...0 Commentaires 0 Parts 887 Vue 0 Aperçu
-
VEGF Inhibitors for Cancer Market Growing at 7.3% CAGR Amid Rising Targeted Oncology TherapiesAccording to a new report from Intel Market Research, the global VEGF Inhibitors for Cancer market was valued at USD 8.42 billion in 2025 and is projected to reach USD 15.67 billion by 2034, growing at a CAGR of 7.3% during the forecast period (2026–2034). This growth trajectory reflects the increasing adoption of targeted therapies in oncology and significant advancements in angiogenesis...0 Commentaires 0 Parts 8KB Vue 0 Aperçu
-
5-Fluorouracil Market Growth Analysis: Expanding Applications in Oncology TherapeuticsThe 5-Fluorouracil (5-FU) Market is poised for steady expansion through 2034, supported by the rising global burden of cancer, increasing chemotherapy adoption, and the growing role of generic oncology drugs. 5-Fluorouracil remains one of the most widely used antimetabolite chemotherapy agents, particularly in the treatment of colorectal, breast, gastrointestinal, pancreatic, and head &...0 Commentaires 0 Parts 508 Vue 0 Aperçu
-
Advancements in Oncology Technologies Fuel Intraoperative Radiation Therapy Market DevelopmentThe global intraoperative radiation therapy market was valued at US$ 121.7 million in 2024 and is projected to reach US$ 266.9 million by 2035. The industry is anticipated to grow at a CAGR of 7.4% from 2025 to 2035, driven by increasing adoption of targeted cancer treatment procedures, advancements in radiation delivery technologies, and rising demand for minimally invasive oncology solutions....0 Commentaires 0 Parts 297 Vue 0 Aperçu
-
Advances in Molecular Oncology Diagnostics Market : Understanding the Market and Its PotentialThe Global Molecular Oncology Diagnostics Market report contains historical, current, and forecast estimation of the revenue generation and profits for each segment and sub-segment of the Molecular Oncology Diagnostics Market in each key region of the world. The report additionally sheds light on the emerging growth opportunities in the business sphere that are anticipated to bolster the growth...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Advancing Cancer Genomics: Clinical Oncology NGS Market in North America by 2034The Clinical Oncology Next Generation Sequencing (NGS) Market is witnessing substantial growth across North America, driven by the increasing adoption of precision medicine, expanding cancer research initiatives, and rising demand for advanced genomic testing solutions. Healthcare providers and research institutions throughout the region are increasingly integrating next generation sequencing...0 Commentaires 0 Parts 372 Vue 0 Aperçu
-
Anthracycline-Based Oncology Drug Class Market Advances with Continued Role in Chemotherapy Regimens and Expanding Cancer Treatment ApplicationsAccording to the latest report published by Data Bridge Market Research, the Anthracycline-Based Oncology Drug Class Market The global anthracycline-based oncology drug class market size was valued at USD 5.40 billion in 2025 and is expected to reach USD 7.33 billion by 2033, at a CAGR of3.90% during the forecast period A talented team works strictly with their potential...0 Commentaires 0 Parts 295 Vue 0 Aperçu
-
Accelerating Cancer Research: Patient Derived Xenograft Model Market Opportunities, Size & Forecast 2031The Patient‑Derived Xenograft Model Market is becoming a critical pillar in oncology research and drug discovery as global demand for predictive preclinical platforms continues to rise. According to the latest market intelligence, the Patient‑Derived Xenograft Model Market was valued at US$ 468.75 million in 2024 and is projected to reach US$ 1,119.36 million by 2031, reflecting a compound...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
All Trans Retinoic Acid Market to Reach USD 780 Million by 2034 | CAGR 4.7%According to a newly published market research report by 24LifeSciences, global all trans retinoic acid market was valued at USD 520 million in 2025 and is projected to reach USD 780 million by 2034, growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 2026–2034. All Trans Retinoic Acid (ATRA), chemically known as tretinoin, is a derivative of vitamin A...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Anti-Radiation Drugs Market Size, Share, and Strategic OutlookAdvancements in biotechnology are enabling the development of more targeted radioprotective treatments. These innovations improve cellular protection while minimizing adverse effects. The evolving therapeutic landscape supports sustained market progress. Future OutlookThe Anti-Radiation Drugs Market is expected to register a CAGR of 6.8% from 2025 to 2031, with a market size expanding from US$...0 Commentaires 0 Parts 7KB Vue 0 Aperçu
-
Basal Cell Carcinoma Therapeutics Market to Reach USD 14.6 Billion by 2032 | CAGR 7.3%According to a newly published market research report by 24LifeSciences, global basal cell carcinoma therapeutics market was valued at USD 8.2 billion in 2024 and is projected to reach USD 14.6 billion by 2032, growing at a compound annual growth rate (CAGR) of 7.3% during the forecast period 2025-2032. Basal Cell Carcinoma (BCC), the most common form of skin cancer accounting for...0 Commentaires 0 Parts 5KB Vue 0 Aperçu
-
Bladder Cancer Market to Reach USD 4.1 Billion by 2031 | CAGR 6.7%According to a newly published market research report by 24LifeSciences, global bladder cancer market was valued at USD 2.6 billion in 2024 and is projected to reach USD 4.1 billion by 2031, growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 2025-2031. Bladder cancer remains one of the most prevalent urological malignancies worldwide, with non-muscle invasive...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Bone Metastasis Therapeutics Market Growth & CAGR 8.3% ForecastAccording to a newly published market research report by 24LifeSciences, global bone metastasis therapeutics market was valued at USD 2.5 billion in 2024 and is projected to reach USD 4.9 billion by 2031, growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252031. Bone metastasis therapeutics comprise a critical class of treatments designed to manage secondary...0 Commentaires 0 Parts 2KB Vue 0 Aperçu
-
Bridging the Digital Health Divide: Enhancing Telehealth through Multilingual Patient EngagementThe global healthcare delivery landscape has undergone an intense digital transformation, with virtual care and telehealth platforms becoming mainstream patient touchpoints. While remote consultations offer unprecedented convenience, they also expose severe systemic language access gaps for Limited English Proficiency (LEP) populations. When patients are unable to articulate their symptoms...0 Commentaires 0 Parts 347 Vue 0 Aperçu
Plus de résultats
Czech
English
Arabic
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek